Prospective Cohort Study of Intravenous Lipid Emulsion for Resuscitating Critically-ill Poisoned Patients



Status:Recruiting
Conditions:Hospital
Therapuetic Areas:Other
Healthy:No
Age Range:Any
Updated:4/12/2017
Start Date:May 2012
End Date:January 2018
Contact:michael levine, md
Email:mdlevine@usc.edu
Phone:323 226 6667

Use our guide to learn which trials are right for you!

The purpose of this project is to evaluate the case characteristics of patients who receive
intravenous lipid emulsion therapy. Previous literature to date has focused on animal
studies or has been primarily limited to case reports or small case series. This
prospectively collected data set will permit a much more detailed description of the use of
lipid, its potential benefits, and potential harms.

The purpose of this project is to evaluate the case characteristics of patients who receive
intravenous lipid emulsion therapy. A secondary objective is to determine the mortality in
this critically ill population of individuals.

Previous literature to date has focused on animal studies or has been primarily limited to
case reports or small case series. This prospectively collected data set will permit a much
more detailed description of the use of lipid, its potential benefits, and potential harms.

Inclusion Criteria:

- receiving intravenous lipid emulsion for treatment of a drug toxicity

- Evaluation of a medical toxicologist as part of the ToxIC registry consortium

Exclusion Criteria:

- not evaluated by a medical toxicologist participating in ToxIC
We found this trial at
2
sites
Los Angeles, California 90033
213) 740-2311
University of Southern California The University of Southern California is one of the world’s leading...
?
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Phoenix, Arizona 85006
?
mi
from
Phoenix, AZ
Click here to add this to my saved trials